Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulipristal Acetate (UPA) Continuous vs Cyclic Regimens for Oral Contraception
NCT01953679Phase 2Completed
- Sponsor
- Premier Research
- Start
- Mar 2014
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ulipristal in contraception (2 arms), sponsored by Premier Research. Primary endpoint: Ovulation inhibition at 6.5 months. Started Mar 2014; status: completed.
02
Drugs
ulipristal
03
Conditions
contraception
Beyond the preview
Go deeper on NCT01953679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01953679.